Skip to main content

METHODS article

Front. Surg., 15 April 2022
Sec. Obstetrics and Gynecological Surgery
This article is part of the Research Topic Challenges, Techniques and Pitfalls in Surgery: How Far Can We Push the Boundaries? View all 21 articles

The Transumbilical Laparoendoscopic Single-Site Extraperitoneal Approach for Pelvic and Para-Aortic Lymphadenectomy: A Technique Note and Feasibility Study

\nShiyi Peng,Shiyi Peng1,2Ying Zheng,
Ying Zheng1,2*Fan Yang,Fan Yang1,2Kana Wang,Kana Wang1,2Sijing Chen,Sijing Chen1,2Yawen WangYawen Wang3
  • 1Department of Gynecology, West China Second Hospital, Sichuan University, Chengdu, China
  • 2Key Laboratory of Obstetrics, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China
  • 3Department of Obstetrics and Gynecology, Shanxi Bethune Hospital, Taiyuan, China

Background: Nowadays, lymphadenectomy could be performed by the transperitoneal or extraperitoneal approach. Nevertheless, each approach has its own advantages and disadvantages. Under these circumstances, we developed a transumbilical laparoendoscopic single-site (TU-LESS) extraperitoneal approach for lymphadenectomy. In this research, the primary goal is to demonstrate the feasibility of the novel approach in systematic lymphadenectomy and present the surgical process step-by-step.

Methods: Between May 2020 and June 2021, patients who had the indications of systematic lymphadenectomy underwent lymphadenectomy via the TU-LESS extraperitoneal approach. This new approach was described in detail, and the clinical characteristics and surgical outcomes were collected and analyzed.

Results: Eight patients with gynecological carcinoma were included in the research, including four with high-risk endometrial cancer and four with early-stage ovarian cancer. The TU-LESS extraperitoneal approach for pelvic and para-aortic lymphadenectomy was successfully performed in all patients without conversion. In all, a median of 26.5 pelvic lymph nodes (range 18–35) and 18.0 para-aortic lymph nodes (range 7–43) were retrieved. There was a median of 166.5 min of surgical time (range 123–205). Patients had speedy recoveries without complications. All patients had positive pain responses after surgery, as well as satisfactory cosmetic and body image outcomes.

Conclusion: Our initial experience showed that it is feasible to perform systematic lymphadenectomy with the TU-LESS extraperitoneal approach. And this new approach may provide a new measure or a beneficial supplement for lymphadenectomy in gynecologic cancer.

Introduction

Lymphadenectomy is paramount for precise staging and tailoring treatment of gynecological malignancies. Compared to laparotomy, laparoscopic surgery caused less surgical trauma and fewer wound complications. The feasibility and safety of minimally invasive surgery for lymphadenectomy has been well-investigated and proved (1, 2). Currently, laparoscopic lymphadenectomy is performed either trans- or extraperitoneally. Dissection of the pelvic lymph nodes (LNs) is easier with the transperitoneal approach; however, the intestinal disruption is a major barrier for para-aortic lymphadenectomy (PALN) (Figure 1). The extraperitoneal approach has been described as a solution to resolve this problem. Without the interference of bowels, the extraperitoneal approach provides an easier access to the infrarenal para-aortic LNs with lower risk of intestinal and urinary injuries (3). The full exposure of surgical field achieved a higher para-aortic LN yield compared to the transperitoneal route (4, 5).

FIGURE 1
www.frontiersin.org

Figure 1. The transperitoneal approach for PALN. (A) The placement of trocars. It was difficult to achieve adequate exposure of para-aortic regions for PALN because of the interference of intestines (B,C). IVC: Inferior vena cava.

Laparoendoscopic single-site (LESS) surgery has emerged as a minimal invasive surgical approach, which could further minimize the surgical trauma compared to multi-port laparoscopy surgery (6). LESS is as safe and effective as the traditional laparoscopy in the gynecologic surgery (7). Compared to patients in the multi-port laparoscopy group, patients in the single-port laparoscopy group attained mild pain with less analgesic consumption and shorter hospital stay (811). The single-port left iliac extraperitoneal PALN was first described by Guoy et al. (12). Subsequently, Lambaudie et al. (13) and Beytout et al. (14) introduced similar single-port lateral approaches. These results indicated that the number of para-aortic LNs retrieved by the single-port lateral extraperitoneal approach was compatible with that of the multi-port extraperitoneal route (3, 10, 13). In spite of this, the most common lateral extraperitoneal technique restraints access to the obturator fossa which impedes pelvic lymphadenectomy (PLN) (15) (Figure 2). Under these circumstances, PLN and other staging procedures sometimes need extra incisions, which increases the amount of trauma experienced throughout the operation. Thus, the TU-LESS extraperitoneal approach, which combines the strengths of LESS with that of extraperitoneal approach was developed to achieve PLN and PALN in a minimal invasive way. This study aims to describe the details of surgical procedures and present our preliminary experience with the TU-LESS extraperitoneal approach for PLN and PALN in order to further evaluate its feasibility.

FIGURE 2
www.frontiersin.org

Figure 2. The lateral extraperitoneal approach for lymphadenectomy. (A) The lateral incisions. (B) Para-aortic LN dissection. Bilateral obturator fossae were challenging to reach when performing pelvic lymphadenectomy (C).

Methods

Patients

This study included eight patients from May 2020 to June 2021. Patients who had indications of systematic lymphadenectomy and were candidates for LESS surgery were eligible for inclusion. Clinical data were collected, including demographics, pathological features, and perioperative outcomes of patients who had the surgery. The study was approved by the institutional review board of the West China Second Hospital, Sichuan University, and all participants provided their written informed consent to participate in this study. The duration of lymphadenectomy time was defined as the interval from the first incision of skin to completion of lymphadenectomy, excluding subsequent procedures such as hysterectomy. The failure of the TU-LESS extraperitoneal approach was defined as the conversion to a transperitoneal approach via laparoscopy or open surgery; and intraoperative complications included peritoneal rupture and damage to intestines, bladder, ureters, nerves, or blood vessels. Postoperative complications included any adverse event that occurred within 30 days after surgery, including lymphocysts, thrombosis, infection, and chyle leakage. Visual analog scoring was used to assess the degree of postoperative pain of umbilical incision 24 h after surgery in the range of 0–10, 0 for no pain, 1–3 for mild pain, 4–6 for moderate pain, and 7–10 for severe pain (16). The body image questionnaire (BIQ) was administered 7 and 30 days after the surgery to assess patient satisfaction with the surgical intervention (17). The BIQ consists of two subscales: body image scale and cosmetic scale (Supplementary Data Sheet 1). With a score from 5 to 20, the body image scale measures perception of patients and their attitude to physical condition. The cosmetic scale evaluates the satisfaction of patients to their umbilical scars with a score from 3 to 24. The higher the score, the more satisfied the patient was with body image and cosmetic effect.

Lymphadenectomy Indications

Dissection of LNs should be recommended for endometrial cancer (EC) patients who are at high risk of recurrence, including those with deep myometrial invasion, high-grade histology, lymphatic vascular invasion, or type II tumors (2). For early-stage EC, the biopsy of sentinel lymph node (SLN) has been proved to be an accurate and effective alternative to lymphadenectomy. However, the use of SLN in high-risk group is controversial, lacking adequate high-level evidences to prove its safety. As a result, systematic lymphadenectomy was nevertheless conducted in this trial on individuals who were considered to be at high risk. In addition, systematic lymphadenectomy was indicated in patients with stage IA-IIA epithelial ovarian carcinoma (OC), except for the mucinous type without suspicious LNs), including those who wished to preserve fertility. Laparoscopy could be employed for patients with early-stage OC by an experienced surgeon (1).

Surgical Technique

All surgical procedures were performed by an experienced gynecologic oncologist. The patient was placed in trendelenburg position with the primary surgeon on the left and the assistant on the opposite sides. First, the primary surgeon made a 2 cm umbilical incision and a multichannel single port (Kangji, Hangzhou, China) was inserted into the intraperitoneal space (Figure 3). Careful transperitoneal exploration was conducted to exclude intra-abdominal carcinomatosis and collect peritoneal washing for cytologic evaluation.

FIGURE 3
www.frontiersin.org

Figure 3. (A) Make a 2-cm umbilical incision. (B) The multichannel single port (Kangji). (C) Set up the port into the intraperitoneal space.

Second, we had to identify the posterior peritoneum above the aortic bifurcation at first and execute a figure-of-eight suture subsequently. The surgeon pulled the thread and the sutured posterior peritoneum was gently raised toward the umbilical incision. Using a purse-string suture, the suspended posterior peritoneum was held in place and marked. Afterwards, the center portion of the suspended posterior peritoneum was gently sliced open (Figure 4, Supplementary Video 1). The third step was to separate the extraperitoneal soft tissues that attached to the anterior peritoneum with blunt-finger dissection in order to expand the extraperitoneal space. Subsequently, the port was repositioned into the retroperitoneal space with the purse-string suture tightened and secured. The microvessels were coagulated by a harmonic scalpel (HARMONIC, Ethicon, America), and carbon dioxide was insufflated at the maximum pressure of 14–20 mmHg to establish the retropneumoperitoneum (Figure 5, Supplementary Video 1).

FIGURE 4
www.frontiersin.org

Figure 4. (A) Make a figure-of-eight on the posterior peritoneum above the aortic bifurcation. (B) Raise the sutured posterior peritoneum to the umbilical incision. (C) Cut open the suspended posterior peritoneum. (D) Reset the port into the retroperitoneal space.

FIGURE 5
www.frontiersin.org

Figure 5. The establishment of the retroperitoneal space. IVC, inferior vena cava.

Procedures were carried out for systematic PLN that included removal of the common iliac, external iliac, internal iliac, obturator, and deep inguinal nodes (Figure 6, Supplementary Video 1). During PALN operations, the surgeon stood between the legs of the patient and the assistant on the right. Para-aortic LNs were dissected from the aortic bifurcation to the left renal vein (RV) (Figure 7, Supplementary Video 1). All surgical specimens were taken out in bags in time to prevent the spillage of tumor cells. And the surgeon sprayed the porcine fibrin sealant kit (Bioseal, Guangzhou, China) onto the surgical field to prevent lymphatic leakage and lymphocyst (18).

FIGURE 6
www.frontiersin.org

Figure 6. Anatomical overview of pelvic area after PLN. (A) The aortic bifurcation and inferior vena cava. (B) The right obturator fossa. (C) The left obturator fossa. (D) The view of presacral area.

FIGURE 7
www.frontiersin.org

Figure 7. Anatomical overview of para-aortic area. (A) Lymphadenectomy up to the left renal vein. (B) The right para-aortic region. (C) Dissection of the interaortocaval and retrocaval lymph nodes. (D) The infrarenal region after PALN.

After the extraperitoneal surgery, the port was reset into the intraperitoneal space for other transperitoneal procedures (i.e., hysterectomy, omentectomy, or salpinx oophorectomy) according to the different types of tumor.

Results

Patient Information

A total of eight patients underwent lymphadenectomy via the TU-LESS extraperitoneal approach. Half of patients were suffering from high-risk EC (one dedifferentiated carcinoma, two grade 3 serous carcinoma with deep myometrial infiltration, and one clear cell carcinoma). The other four patients were diagnosed with early-stage epithelial OC (two serous carcinoma, one clear cell carcinoma, and one endometrioid carcinoma), and three of them opted for fertility-sparing surgery (i.e., preservation of the uterus and contralateral adnexa). The median age was 44 years (range 22–64), and the median BMI was 23.1 kg/m2 (range 20.7–28.4). According to the Chinese criteria, two patients were classified as obese (BMI = 28.2 and 28.4 kg/m2) (19). In this group, half had a history of abdominal surgery, and one even had undergone four surgeries. The clinical characteristics of patients are summarized in Table 1.

TABLE 1
www.frontiersin.org

Table 1. Patient characteristics.

Surgical Outcomes

Table 2 displays the operative outcomes. The upper limit of PALN for all patients was at the renal vascular level. The median time of LN dissection was 166.5 min (range 123–205). During the procedure, no intraoperative complications were observed and no conversion to transperitoneal approach or multiport laparoscopic surgery occurred. The median blood loss was 100 ml (range 100–300) and no patient required blood transfusion. Concerning the LN yields, the median count of para-aortic LNs was 18 (range of 7–30), and the retrieved pelvic LNs was 26.5 (range 18–35). Three EC patients had positive LNs, two with pelvic nodal metastasis and one with para-aortic nodal involvement. Furthermore, there was no evidence of LN metastasis in OC patients. The median flatus time was 23.0 h (range 16.0–38.0) and the median hospital duration was 3 days (range of 2–4). All patients felt mild pain for 24 h after surgery with a median score of 2 (range 1–3). The median satisfaction value for body image was 17 (range 16–19) 7 days after surgery and increased to 19.5 (range 18–20) a month after surgery; while the median score of cosmetic effects was 18 (range 15–19) 1 week after surgery and improved to 22.5 (range 21–23) after 30 days (Figure 8).

TABLE 2
www.frontiersin.org

Table 2. Surgical and postoperative information.

FIGURE 8
www.frontiersin.org

Figure 8. The umbilical incisions of the TU-LESS extraperitoneal approach. (A) The preoperative appearance. (B) The postoperative appearance. (C) The appearance 3 months after surgery.

Discussion

Lymph node status evaluation is a critical component of thorough surgical staging for ovarian and EC (2022). Laparoscopic lymphadenectomy has been proven safe for surgical staging in EC and early-stage OC patients with less complications and faster recovery (1, 2, 23). Previous studies have shown that extraperitoneal lymphadenectomy is superior to the transperitoneal approach for PALN, because it could avoid intestinal interference and allow an easier access to supramesenteric LNs (5, 24, 25). We initially attempted to employ the TU-LESS extraperitoneal approach in the surgical staging procedures for a patient with advanced cervical cancer in order to accurately delineate the radiographic field. The PALN and right enlarged obturator LN biopsy were performed easily via this novel technique (26). Further exploration and practice of this technique were conducted, and the primary findings of our study confirmed that the TU-LESS extraperitoneal approach is feasible for systematic PLN and PALN.

Compared to the node counts of laparoscopic transperitoneal procedure (range 14–22) (11, 13, 2729), our method yielded a comparable number of pelvic LNs. The median count of para-aortic LNs (18, range 7–30) in our investigation was equivalent to that of the largest case series of single-port lateral extraperitoneal approach reported by Guoy (median 18, range 2–47) (3), but was higher than that of left-sided extraperitoneal approach using multiport laparoscopy (range 9.5–15) (3, 5, 14, 30). Despite the left extraperitoneal approach being viable for completing the aortic nodal dissection, Dargent asserted that the number of right-sided aortic sampling had reduced compared to bilateral extraperitoneal approach (p < 0.01) (31). Furthermore, being limited in access to the deep obturator fossae was one of major technical difficulties of the left-sided approach, which was mainly due to the poor angle of view (13, 15, 32) (as Figure 2C shows). Some technique modifications were made to overcome this difficulty, such as addition of different incisions. Querleu added two incisions on the basis of the left-sided extraperitoneal approach in order to achieve obturator node sampling for patients with locally advanced cervical cancer (32). However, whether this technique could be applied in systematic PLN remains to be verified, and the authors further noted that right obturator fossa was obviously difficult to reach with this technique. Other methods for pelvic LN dissection were also reported, such as combining a right extraperitoneal approach (33). Nonetheless, these modifications would increase surgical trauma, and there were few studies that investigated the feasibility for systematic PLN. One of the greatest merits of the TU-LESS extraperitoneal approach is that it allows equal access to the bilateral pelvic and para-aortic areas through the same extraperitoneal approach because the umbilical incision is centrally located, which facilitates the obturator and infrarenal LN dissection (Figures 6, 7). Additionally, careful contrast of Figures 2C, 6, 7 showed that the anatomic angles during the lateral extraperitoneal procedures were altered, adding to identification complexity for surgeons. However, surgeons did not need to readapt to the changing anatomic angles with the TU-LESS extraperitoneal approach, since the angle of view was the same as the transperitoneal approach or laparotomy which many surgeons have been accustomed to.

Reducing intraperitoneal adhesion is another significant advantage of the extraperitoneal approach. Occelli et al. compared the adhesion rate of laparoscopic transperitoneal vs. extraperitoneal PALN on pigs. The results showed that the extraperitoneal group had a lower adhesion formation rate than the transperitoneal group (p = 0.04) (15). Abdominal adhesion is likely to increase the morbidity associated with radiotherapy and may result in adnexal adhesion or even infertility (34, 35). The TU-LESS extraperitoneal approach also theoretically has this advantage, because it could minimize peritoneal injury and leave the peritoneal cavity intact after surgery. For these reasons, in our research, the TU-LESS extraperitoneal approach was considered to be an optimal treatment for young patients who wish to preserve their fertility. Three patients with epithelial OC received the fertility preservation surgery. All of them completed the comprehensive assessment of LNs and dissected lesions with little peritoneal damage. While peritoneal cavity could remain intact with our technique, however, the fertility outcomes ought to be followed. Additionally, patients who underwent abdominal surgeries might potentially benefit from the TU-LESS extraperitoneal approach since it avoids adhesiolysis, and thus it could reduce the risk of intra-abdominal organ injury. In our analysis, half of the patients had surgical history, and none of them had intraperitoneal complications. To sum up, different approaches for lymphadenectomy have their own strengths and limitations; and the concerned summarization from our current exploration and prior studies are presented in Table 3.

TABLE 3
www.frontiersin.org

Table 3. Advantages and limitations of three approaches for lymphadenectomy.

In previous studies, the lymphadenectomy time of the lateral extraperitoneal approach was varied (range 125–339.5 min) (3, 25, 30, 36). The time required for lymphadenectomy in this study was in concordance with the prior findings, but it was less than the time of early practice of the single-port extraperitoneal approach for PALN (average 240 min, range 180–270 min) described by Guoy et al. (37). However, our lymphadenectomy time was somewhat longer than the single-port transperitoneal approach for PLN and PALN (range 60–185 min) (13), which might be explained by the extra time needed to establish the retropneumoperitoneum. The operation time may decrease when the learning curve climbs.

In our research, there were no complications during or after surgery, nor was there a conversion to the transperitoneal route. The procedural failure of the extraperitoneal approach was attributed to the peritoneal rupture (38). Peritoneal rupture occurred in seven patients (16%) during the lateral single-port extraperitoneal lymphadenectomy according to Beytout (14). Neither a peritoneal rupture nor any other technical problems have ever caused abortion of extraperitoneal operation in our series.

Additionally, some studies indicated that the extraperitoneal approach may be an optimal option for patients with a high BMI. Dowdy et al. (39) and Pakish et al. (25) confirmed that patients with BMI >35 kg/m2, who had extraperitoneal PALN, harvested more para-aortic nodes than those who underwent abdominal or transperitoneal PALN. BMI had no effect on the duration of surgery, and the area of visceral adipose tissues did not affect the extraperitoneal approach of PALN (40). According to earlier studies, the maximum BMI of patients who underwent the extraperitoneal lymphadenectomy was ranging from 31 to 40 kg/m2 (1, 3, 9, 11, 20). Nonetheless, we successfully performed the TU-LESS extraperitoneal technique on two obese patients who satisfied Chinese diagnostic criteria (BMI ≥28 kg/m2). However, since this was a primary exploration with a limited number of patients, we did not try to use this measure for systematic lymphadenectomy in patients with BMI more than 30 kg/m2. We were exploring an easier method for establishing extraperitoneal space in obese patients. The feasibility and safety of robotic technology for lymphadenectomy in gynecologic cancer have been validated, with the benefits of a three-dimensional vision, scaled movement, and short learning curves (41). Gallotta demonstrated that the robotic technology is conducive for PALN. The results showed that aortic LN yields were comparable when patients with BMI >30 kg/m2 were compared with those with BMI <30 kg/m2 (42).The robotic surgery was likely to be a preferable approach for obese patients, and the node counts were not affected by increasing BMI (43). Combining robotic technology and the TU-LESS extraperitoneal approach for lymphadenectomy may provide a potential and feasible option for obese patients. Robotic technology may facilitate in shortening the learning curve of the TU- LESS extraperitoneal approach and implementing it.

Conclusion

In conclusion, the TU-LESS extraperitoneal approach for pelvic and PALN is feasible with a practical application. It significantly improves the exposure and visualization for PLN and PALN, while causing minimal surgical trauma. Depending on the results of our study, this innovative approach may become an effictive alternative measure to the transperitoneal and lateral extraperitoneal approach. However, further studies are required to compare the surgical outcomes like LN yields, surgical trauma, cosmesis, and other index among three approaches. Additionally, based on the current research, a long-term clinical application on a larger sample would be required to evaluate the effects in a more objective manner.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics Statement

The studies involving human participants were reviewed and approved by the Medical Institutional Review Board of West China Second Hospital of Sichuan University. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author Contributions

SP contributed to writing the manuscript and drawing pictures. YZ designed the study and revised the manuscript. FY and KW analyzed and interpreted the data. SC and YW made the video and collected the data. All authors contributed to the manuscript and approved the final manuscript.

Funding

This work was supported by the Science and Technology Program of Sichuan, China (2020YFS0049), and the Chengdu Science and Technology Bureau (2019-YF05-00473-SN).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fsurg.2022.863078/full#supplementary-material

Supplementary Video 1. The TU-LESS extraperitoneal approach for systematic lymphadenectomy.

Supplementary Data Sheet 1. The Body Image Questionnaire (BIQ).

References

1. Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, et al. Ovarian cancer, version 2.2020, Nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. (2021) 19:191–226. doi: 10.6004/jnccn.2021.0007

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, et al. Nccn guidelines® insights: uterine neoplasms, version 3.2021. J Natl Compr Canc Netw. (2021) 19:888–95. doi: 10.6004/jnccn.2021.0038

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Gouy S, Uzan C, Scherier S, Gauthier T, Bentivegna E, Kane A, et al. Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients. Surg Endosc. (2014) 28:249–56. doi: 10.1007/s00464-013-3180-4

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Díaz-Feijoo B, Bebia V, Hernández A, Gilabert-Estalles J, Franco-Camps S, de la Torre J, et al. Surgical complications comparing extraperitoneal vs transperitoneal laparoscopic aortic staging in early stage ovarian and endometrial cancer. Gynecol Oncol. (2021) 160:83–90. doi: 10.1016/j.ygyno.2020.10.038

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Zhang W, Xia L, Han X, Ju X, Wu X, Chen X. Extraperitoneal laparoscopy for para-aortic lymphadenectomy in endometrial carcinoma staging: an approach with higher efficiency. World J Surg Oncol. (2021) 19:323. doi: 10.1186/s12957-021-02416-x

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Spana G, Rane A, Kaouk JH. Is robotics the future of laparoendoscopic single-site surgery (less)? BJU Int. (2011) 108:1018–23. doi: 10.1111/j.1464-410X.2011.10513.x

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Song T, Kim ML, Jung YW, Yoon BS, Joo WD, Seong SJ. Laparoendoscopic single-site versus conventional laparoscopic gynecologic surgery: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol. (2013) 209:317.e1–9. doi: 10.1016/j.ajog.2013.07.004

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Michener CM, Lampert E, Yao M, Harnegie MP, Chalif J, Chambers LM. Meta-analysis of laparoendoscopic single-site and vaginal natural orifice transluminal endoscopic hysterectomy compared with multiport hysterectomy: real benefits or diminishing returns? J Minim Invasive Gynecol. (2021) 28:698–709.e1. doi: 10.1016/j.jmig.2020.11.029

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Yuan JB, Chen MF, Qi L, Li Y, Li YL, Chen C, et al. Preservation of the saphenous vein during laparoendoscopic single-site inguinal lymphadenectomy: comparison with the conventional laparoscopic technique. BJU Int. (2015) 115:613–8. doi: 10.1111/bju.12838

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Hudry D, Cannone F, Houvenaeghel G, Buttarelli M, Jauffret C, Chéreau E, et al. Comparison of single-port laparoscopy and conventional laparoscopy for extraperitoneal para-aortic lymphadenectomy. Surg Endosc. (2013) 27:4319–24. doi: 10.1007/s00464-013-3051-z

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Fagotti A, Boruta DM, 2nd, Scambia G, Fanfani F, Paglia A, Escobar PF. First 100 early endometrial cancer cases treated with laparoendoscopic single-site surgery: a multicentric retrospective study. Am J Obstet Gynecol. (2012) 206:353.e1–6. doi: 10.1016/j.ajog.2012.01.031

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Gouy S, Uzan C, Kane A, Gauthier T, Morice P. Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy: 3 consecutive cases. Int J Gynecol Cancer. (2011) 21:1695–7. doi: 10.1097/IGC.0b013e31822a0175

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lambaudie E, Cannone F, Bannier M, Buttarelli M, Houvenaeghel G. Laparoscopic extraperitoneal aortic dissection: does single-port surgery offer the same possibilities as conventional laparoscopy? Surg Endosc. (2012) 26:1920–3. doi: 10.1007/s00464-011-2126-y

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Beytout C, Laas E, Naoura I, Bendifallah S, Canlorbe G, Ballester M, et al. Single-port extra- and transperitoneal approach for paraaortic lymphadenectomy in gynecologic cancers: a propensity-adjusted analysis. Ann Surg Oncol. (2016) 23:952–8. doi: 10.1245/s10434-015-4874-8

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Occelli B, Narducci F, Lanvin D, Querleu D, Coste E, Castelain B, et al. De novo adhesions with extraperitoneal endosurgical para-aortic lymphadenectomy versus transperitoneal laparoscopic para-aortic lymphadenectomy: a randomized experimental study. Am J Obstet Gynecol. (2000) 183:529–33. doi: 10.1067/mob.2000.105736

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Fagotti A, Bottoni C, Vizzielli G, Gueli Alletti S, Scambia G, Marana E, et al. Postoperative pain after conventional laparoscopy and laparoendoscopic single site surgery (less) for benign adnexal disease: a randomized trial. Fertil Steril. (2011) 96:255–9.e2. doi: 10.1016/j.fertnstert.2011.04.006

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Dunker MS, Stiggelbout AM, van Hogezand RA, Ringers J, Griffioen G, Bemelman WA. Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for crohn's disease. Surg Endosc. (1998) 12:1334–40. doi: 10.1007/s004649900851

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Gasparri ML, Ruscito I, Bolla D, Benedetti Panici P, Mueller MD, Papadia A. The efficacy of fibrin sealant patches in reducing the incidence of lymphatic morbidity after radical lymphadenectomy: a meta-analysis. Int J Gynecol Cancer. (2017) 27:1283–92. doi: 10.1097/IGC.0000000000001051

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Coorperative Meta analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related disease in Chinese adult population. Chin J Epidemiol. (2002) 1:10–5.

Google Scholar

20. O'Hanlan KA, Sten MS, O'Holleran MS, Ford NN, Struck DM, McCutcheon SP. Infrarenal lymphadenectomy for gynecological malignancies: two laparoscopic approaches. Gynecol Oncol. (2015) 139:330–7. doi: 10.1016/j.ygyno.2015.09.019

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Koo YJ, Kim JE, Kim YH, Hahn HS, Lee IH, Kim TJ, et al. Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes. J Gynecol Oncol. (2014) 25:111–7. doi: 10.3802/jgo.2014.25.2.111

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Kong Q, Wei H, Zhang J, Li Y, Wang Y. Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis. J Ovarian Res. (2021) 14:45. doi: 10.1186/s13048-021-00793-1

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Gallotta V, Petrillo M, Conte C, Vizzielli G, Fagotti A, Ferrandina G, et al. laparoscopic versus laparotomic surgical staging for early-stage ovarian cancer: a case-control study. J Minim Invasive Gynecol. (2016) 23:769–74. doi: 10.1016/j.jmig.2016.03.006

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Prodromidou A, Machairas N, Spartalis E, Kostakis ID, Iavazzo C, Moris D, et al. Transperitoneal versus extraperitoneal laparoscopic lymphadenectomy for gynecological malignancies: a systematic review and meta-analysis. Anticancer Res. (2018) 38:4677–81. doi: 10.21873/anticanres.12773

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Pakish J, Soliman PT, Frumovitz M, Westin SN, Schmeler KM, Reis RD, et al. A Comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. (2014) 132:366–71. doi: 10.1016/j.ygyno.2013.12.019

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Chen S, Zhou J, Zheng Y, Wang K, Yang X. Para-aortic and right obturator lymphadenectomy for surgical staging of advanced cervical cancer through the tu-less extraperitoneal approach. J Minim Invasive Gynecol. 2021) 28:1140. doi: 10.1016/j.jmig.2020.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Boruta DM, Fagotti A, Bradford LS, Escobar PF, Scambia G, Kushnir CL, et al. Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive cervical cancer. J Minim Invasive Gynecol. (2014) 21:394–8. doi: 10.1016/j.jmig.2013.10.005

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Paik ES, Baek SH, Kang JH, Jeong SY, Kim MS, Kim WY, et al. Comparison of laparoscopy and laparotomy for para-aortic lymphadenectomy in women with presumed stage i-ii high-risk endometrial cancer. Front Oncol. (2020) 10:451. doi: 10.3389/fonc.2020.00451

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Larciprete G, Casalino B, Segatore MF, Jarvis S, Catarinella V, Cirese E. Pelvic lymphadenectomy for cervical cancer: extraperitoneal versus laparoscopic approach. Eur J Obstet Gynecol Reprod Biol. (2006) 126:259–63. doi: 10.1016/j.ejogrb.2005.09.019

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Iacoponi S, De Santiago J, Diestro MD, Hernandez A, Zapardiel I. Single-port laparoscopic extraperitoneal para-aortic lymphadenectomy. Int J Gynecol Cancer. (2013) 23:1712–6. doi: 10.1097/IGC.0000000000000006

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Dargent D, Ansquer Y, Mathevet P. Technical development and results of left extraperitoneal laparoscopic paraaortic lymphadenectomy for cervical cancer. Gynecol Oncol. (2000) 77:87–92. doi: 10.1006/gyno.1999.5585

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Querleu D, Ferron G, Rafii A, Bouissou E, Delannes M, Mery E, et al. Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique. Gynecol Oncol. (2008) 109:81–5. doi: 10.1016/j.ygyno.2007.12.031

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Pan XY, Lin H, Wang YN, Zhao YW, Cheng JY, Sun AP. Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in gynecologic malignancies. Gynecol Oncol. (2011) 122:281–4. doi: 10.1016/j.ygyno.2011.04.048

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Vergote I, Pouseele B, Van Gorp T, Vanacker B, Leunen K, Cadron I, et al. Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients. Acta Obstet Gynecol Scand. (2008) 87:783–7. doi: 10.1080/00016340802146946

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Mabuchi S, Kimura T. Extraperitoneal radical trachelectomy with pelvic lymphadenectomy: a novel fertility-preserving option for early stage cervical cancer patients. Int J Gynecol Cancer. (2017) 27:537–42. doi: 10.1097/IGC.0000000000000918

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Schuman S, Lucci JA 3rd, Twiggs LB. Laparoendoscopic single-site extraperitoneal aortic lymphadenectomy: first experience. J Laparoendosc Adv Surg Tech A. (2011) 21:251–4. doi: 10.1089/lap.2010.0362

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Gouy S, Uzan C, Kane A, Scherier S, Gauthier T, Bentivegna E, et al. A new single-port approach to perform a transperitoneal step and an extraperitoneal para-aortic lymphadenectomy with a single incision. J Am Coll Surg. (2012) 214:e25–30. doi: 10.1016/j.jamcollsurg.2012.02.012

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Morales S, Zapardiel I, Grabowski JP, Hernandez A, Diestro MD, Gonzalez-Benitez C, et al. Surgical outcome of extraperitoneal paraaortic lymph node dissections compared with transperitoneal approach in gynecologic cancer patients. J Minim Invasive Gynecol. (2013) 20:611–5. doi: 10.1016/j.jmig.2013.03.009

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy–a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. (2008) 111:418–24. doi: 10.1016/j.ygyno.2008.08.021

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Nakao K, Sasaki H, Nishimura T, Banno H, Otsuka K, Hirabuki S, et al. Periaortic abdominal fat area as a predictor of surgical difficulties during extraperitoneal laparoscopic para-aortic lymphadenectomy. J Minim Invasive Gynecol. (2020) 27:1377–82. doi: 10.1016/j.jmig.2019.10.016

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Gallotta V, Giudice MT, Conte C, Sarandeses AV, D'Indinosante M, Federico A, et al. Minimally invasive salvage lymphadenectomy in gynecological cancer patients: a single institution series. Eur J Surg Oncol. (2018) 44:1568–72. doi: 10.1016/j.ejso.2018.08.006

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Gallotta V, Federico A, Gaballa K, D'Indinosante M, Conte C, Giudice MT, et al. The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience. J Surg Oncol. (2019) 119:355–60. doi: 10.1002/jso.25335

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Cunningham MJ, Dorzin E, Nguyen L, Anderson E, Bunn WD Jr. Body mass index, conversion rate and complications among patients undergoing robotic surgery for endometrial carcinoma. J Robot Surg. (2015) 9:339–45. doi: 10.1007/s11701-015-0538-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: extraperitoneal approach, pelvic lymphadenectomy, para-aortic lymphadenectomy, laparoendoscopic single-site (LESS) surgery, ovarian cancer, endometrial cancer

Citation: Peng S, Zheng Y, Yang F, Wang K, Chen S and Wang Y (2022) The Transumbilical Laparoendoscopic Single-Site Extraperitoneal Approach for Pelvic and Para-Aortic Lymphadenectomy: A Technique Note and Feasibility Study. Front. Surg. 9:863078. doi: 10.3389/fsurg.2022.863078

Received: 26 January 2022; Accepted: 07 March 2022;
Published: 15 April 2022.

Edited by:

Stefano Cianci, University of Messina, Italy

Reviewed by:

Carmine Conte, Agostino Gemelli University Polyclinic (IRCCS), Italy
Nicolò Bizzarri, Agostino Gemelli University Polyclinic (IRCCS), Italy

Copyright © 2022 Peng, Zheng, Yang, Wang, Chen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ying Zheng, zhy_chd@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.